Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard I Evan

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
The Journal of General Virology|May 29, 2004
The cell cycle and how it is steered by Kaposi's sarcoma-associated herpesvirus cyclinEmmy W Verschuren, Nic Jones, Gerard I Evan
Cell|December 22, 2006
Modeling the therapeutic efficacy of p53 restoration in tumorsCarla P Martins, Lamorna Brown-Swigart, Gerard I Evan
Cold Spring Harbor Protocols|March 4, 2015
The estrogen receptor fusion system in mouse models: a reversible switchJonathan Whitfield, Trevor Littlewood, Gerard I Evan, et al.
Cancer Cell|September 21, 2002
The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivoEmmy W Verschuren, Juha Klefstrom, Gerard I Evan, et al.
Molecular and Cellular Biology|February 18, 2004
Id2 is dispensable for Myc-induced epidermal neoplasiaDaniel J Murphy, Lamorna Brown Swigart, Mark A Israel, et al.
The Journal of Biological Chemistry|February 9, 2006
Specific requirement for Bax, not Bak, in Myc-induced apoptosis and tumor suppression in vivoTobias B Dansen, Jonathan Whitfield, Fanya Rostker, et al.
Oncogene|June 23, 2004
Defining the temporal requirements for Myc in the progression and maintenance of skin neoplasiaIgnacio Flores, Daniel J Murphy, Lamorna Brown Swigart, et al.
Molecular and Cellular Biology|July 29, 2009
Acute overexpression of Myc in intestinal epithelium recapitulates some but not all the changes elicited by Wnt/beta-catenin pathway activationAndrew J Finch, Laura Soucek, Melissa R Junttila, et al.
Cancer Cell|December 13, 2006
Mdm2 is critically and continuously required to suppress lethal p53 activity in vivoIngo Ringshausen, Clodagh C O'Shea, Andrew J Finch, et al.
Cancer Research|September 18, 2004
c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanismUlrike E Knies-Bamforth, Stephen B Fox, Richard Poulsom, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
The Journal of General Virology|May 29, 2004
The cell cycle and how it is steered by Kaposi's sarcoma-associated herpesvirus cyclinEmmy W Verschuren, Nic Jones, Gerard I Evan
Cell|December 22, 2006
Modeling the therapeutic efficacy of p53 restoration in tumorsCarla P Martins, Lamorna Brown-Swigart, Gerard I Evan
Cold Spring Harbor Protocols|March 4, 2015
The estrogen receptor fusion system in mouse models: a reversible switchJonathan Whitfield, Trevor Littlewood, Gerard I Evan, et al.
Cancer Cell|September 21, 2002
The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivoEmmy W Verschuren, Juha Klefstrom, Gerard I Evan, et al.
Molecular and Cellular Biology|February 18, 2004
Id2 is dispensable for Myc-induced epidermal neoplasiaDaniel J Murphy, Lamorna Brown Swigart, Mark A Israel, et al.
The Journal of Biological Chemistry|February 9, 2006
Specific requirement for Bax, not Bak, in Myc-induced apoptosis and tumor suppression in vivoTobias B Dansen, Jonathan Whitfield, Fanya Rostker, et al.
Oncogene|June 23, 2004
Defining the temporal requirements for Myc in the progression and maintenance of skin neoplasiaIgnacio Flores, Daniel J Murphy, Lamorna Brown Swigart, et al.
Molecular and Cellular Biology|July 29, 2009
Acute overexpression of Myc in intestinal epithelium recapitulates some but not all the changes elicited by Wnt/beta-catenin pathway activationAndrew J Finch, Laura Soucek, Melissa R Junttila, et al.
Cancer Cell|December 13, 2006
Mdm2 is critically and continuously required to suppress lethal p53 activity in vivoIngo Ringshausen, Clodagh C O'Shea, Andrew J Finch, et al.
Cancer Research|September 18, 2004
c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanismUlrike E Knies-Bamforth, Stephen B Fox, Richard Poulsom, et al.
Pageof 8